Oncoinvent Asa Is A Norwegian Company Founded In 2010Dedicated To Developing Innovativeradiopharmaceutical Products For Cancer Treatmentthecompany Was Established By Drroy Hlarsen And Professor A Yvind Sbrulandwho Havesignificant Expertisein Radionuclidebased Therapiesthey Areknown For Their Contributions To Thefirst Fda And Ema Approved Alpha Emitting Pharmaceuticalxofigoa And Thebeta Emitting Candidatebetalutinathecompany S Lead Product Candidateis Radspherina An Alpha Emitting Radioactivemicrospheresuspension Aimed At Treating Metastatic Cancers In Body Cavitiesradspherinahas Shown Promisein Reducing Tumor Cell Growthwith Its First Clinical Indication Targeting Peritoneal Carcinomatosisoncoinvent Asa Collaborates With Clinical Research Centers In Europeand Theu Sto Advanceits Product Developmentreflecting Its Commitment To Innovation In Cancer Treatmentheadquartered In Oslonorwaythecompany Operates With A Smallspecialized Team Focused On Its Mission
No conferences found for this company.
| Company Name | Oncoinvent As |
| Country |
Norway
|
| Address | N/A |
| Telephone | N/A |
| N/A |
